How to 'drug' our way out of the obesity crisis (or not): the roll-out of semaglutide

Br J Gen Pract. 2024 Apr 25;74(742):218. doi: 10.3399/bjgp24X737241. Print 2024 May.
No abstract available

MeSH terms

  • Anti-Obesity Agents / therapeutic use
  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Obesity* / drug therapy
  • Weight Loss / drug effects

Substances

  • semaglutide
  • Glucagon-Like Peptides
  • Anti-Obesity Agents
  • Hypoglycemic Agents